Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : THE WHITE HOUSE -- Ignore unavailable to you. Want to Upgrade?

To: TideGlider who wrote (24700)	10/28/2008 12:12:59 PM
From: Gersh Avery	Respond to of 25737

Wrong.

To: TideGlider who wrote (24700)	10/28/2008 12:17:30 PM
From: longnshort	1 Recommendation Read Replies (2) \| Respond to of 25737

he's high

To: TideGlider who wrote (24700)	10/28/2008 1:04:56 PM
From: DuckTapeSunroof	Respond to of 25737

LOL, "controlled" ain't the half of it! In this particular area, how about "research VETOED and blocked by the federal bureaucracy".... Not THAT'S "controlled"! <g>

To: TideGlider who wrote (24700)	11/4/2008 2:25:50 AM
From: Gersh Avery	Read Replies (1) \| Respond to of 25737

Thought you might find this interesting: Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado SAN FRANCISCO, Oct. 22 Dynamic Alert Limited (OTC Bulletin Board: DYMC) (the "Company") is an emerging biotechnology leader specializing in the commercialization of medical cannabis-based pharmaceutical products. Today the Company is pleased to announce it has signed an agreement to acquire all of the assets of Cannex, a privately owned California group operated by Medical Cannabis pioneer and political activist Steven W. Kubby (http://www.kubby.com). The asset purchase agreement includes all intellectual property rights, formulas, patents, trademarks, client base, hardware and software, etc... pertaining to Cannex's pharmaceutical cannabis research & development business. Dynamic Alert anticipates closing this transaction upon completion of a 90-day due diligence period. Richard Cowan, Dynamic President & CEO, stated, "Mr. Kubby's background in the medical cannabis arena is simply put, the living proof that it works. Mr. Kubby, the founder of Cannex, is a long-term cancer survivor. Mr. Kubby is an entrepreneur with a wide range of experience and success in businesses ranging from property management to publishing to political fundraising. He received his BA in Psychobiology from California State University. Kubby is a survivor, for more than three decades, of a rare form of adrenal cancer with a mortality prognosis of 6-12 months. Leading specialists in the US and Canada have attributed his survival to medical cannabis. Mr. Kubby is a director of the American Medical Marijuana Association, an internationally recognized organization comprised of doctors, lawyers, nurses and patients working for the rights of medical cannabis patients primarily in the United States. Having been a leader in the passing of California's medical cannabis initiative (Proposition 215) in 1996, Kubby is intimately familiar with the legal and regulatory problems involved in developing and marketing cannabinoid-based pharmaceuticals." As well, Dynamic Alert has just appointed world-renowned Medical Cannabis Research expert Dr. Robert Melamede as its newest Director and Chief Science Officer. Dr. Melamede has a Ph.D. in Molecular Biology and Biochemistry from the City University of New York. He retired as Chairman of the Biology Department at University of Colorado, Colorado Springs in 2005, where he continues to teach and research cannabinoids, cancer, and DNA repair. Dr. Melamede is recognized as a leading authority on the therapeutic uses of cannabis, and has authored or co-authored dozens of papers on a wide variety of scientific subjects. Dr. Melamede also serves on the Advisory Board of The Journal of the International Association for Cannabis as Medicine, and the Scientific Advisory Board Medical of the Marijuana Policy Advocacy Project, as well as the Scientific Advisory Board of Americans for Safe Access. Please visit youtube.com to view one of many video speeches by Dr. Robert Melamede speaking on the effectiveness of Medical Cannabinoids. Dynamic Alert President & CEO, Richard Cowan added, "This is truly a great step for Dynamic Alert, because this transaction and the addition of Dr. Melamede to our team will certainly expedite our plans to bring critical pharmaceutical cannabis products to market. Cannex has several innovative formulations in various stages development, including a lozenge that has just gone through informal human trials by a Canadian Compassion Society with outstanding results. We have updated our website, dynamicalertlimited.com to keep our shareholders informed as we progress through our plans to become a leader in pharmaceutical cannabis products." prnewswire.com